1. Patients launch a $1.27 million crowdfunding campaign for ME/CFS gut microbiome study.
    Check out the website, Facebook and Twitter. Join in donate and spread the word!
Leptin
Andrew Gladman reflects upon the recent IACFS/ME conference and the buzz surrounding a small molecule, leptin.
Discuss the article on the Forums.

HEB (maker of Ampligen) paradoxically rated among favorite small cap stocks

Discussion in 'General ME/CFS News' started by WillowJ, Jul 11, 2011.

  1. WillowJ

    WillowJ Senior Member

    Messages:
    2,890
    Likes:
    2,287
    WA, USA
    the article says this is perplexing, "suspicious," and perhaps based on "hope," since there is no new news:
    http://www.smallcapnetwork.com/Real...CBAI-HEB/s/via/10/article/view/p/mid/3/id/18/

    I wonder if it has to do with investors reading the MLV abstracts from the International Human Retrovirus conference and realizing that retroviral causation could actually be a factor?

    I don't doubt that ampligen can help some deserving patients who need options, but I wonder if HEB can pull off readying a medication. More investors could help!

    Odd that the article says ampligen is for "chronic fatigue syndrome (CFS)", when Hemispherx says it's for important neuro-immune diseases. The article could at least use ME/CFS and spell out Myalgic Encephalomyelitis even if it didn't want to use space explaining what disease this is.

See more popular forum discussions.

Share This Page